Table I.
Previous chemotherapy and reason for discontinuation | All patients (n=17), no. (%) |
---|---|
Fluoropyrimidine | |
Refractory | 17 (100) |
Intolerant | 0 |
Oxaliplatin | |
Refractory | 16 (94) |
Intolerant | 1 (6) |
Irinotecan | |
Refractory | 15 (88) |
Intolerant | 2 (12) |
Angiogenesis inhibitor | |
Refractory | 17 (100) |
Intolerant | 0 |
Anti-EGFR antibody | |
Refractory | 8 (47) |
Intolerant | 1 (6) |
RAS mutational status | |
Wild-type | 9 (53) |
Mutant | 8 (47) |
EGFR, epidermal growth factor receptor.